Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland
ContributorsAlberio, Lorenzo; Angelillo-Scherrer, Anne; Asmis, Lars; Casini, Alessandro![orcid](assets/images/orcid.png)
; Fontana, Pierre; Graf, Lukas; Hegemann, Inga; Kremer Hovinga, Johanna A.; Korte, Wolfgang; Lecompte, Thomas Pierre; Martinez, Martina; Nagler, Michael; Studt, Jan-Dirk; Tsakiris, Dimitrios A.; Wuillemin, Walter; Working Party Hemostasis (WPH) of the Swiss Society of Hematology (SGH-SSH)
![orcid](assets/images/orcid.png)
Published inSwiss Medical Weekly, vol. 150, w20210
Publication date2020
Abstract
Keywords
- Anticoagulation
- Argatroban
- Bivalirudin
- Danaparoid
- Fondaparinux
- Heparin
- Heparin-induced thrombocytopenia
- HIT
- Direct oral anticoagulants
- Rivaroxaban
Affiliation
Citation (ISO format)
ALBERIO, Lorenzo et al. Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland. In: Swiss Medical Weekly, 2020, vol. 150, p. w20210. doi: 10.4414/smw.2020.20210
Main files (1)
Article (Published version)
Identifiers
- PID : unige:145792
- DOI : 10.4414/smw.2020.20210
- PMID : 32329806
Commercial URLhttps://doi.emh.ch/smw.2020.20210
ISSN of the journal1424-3997